RaySearch releases RayCare v2025

June 27, 2025 04:17 AM PDT | By EODHD
 RaySearch releases RayCare v2025
Image source: Kalkine Media
STOCKHOLM, June 27, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the release of RayCare®* v2025, the latest version of its next-generation oncology information system. The new release delivers powerful functionality enhancements that streamline clinical workflows, improve data management, and strengthen interoperability across the treatment chain. RayCare v2025 introduces several key innovations designed to simplify daily work for oncology professionals. Seamless integration with Microsoft Word now allows users to generate and update patient-related documents directly within the patient chart – supporting consistent, efficient clinical documentation. Imaging workflows are optimized with DICOM Modality Worklist integration, enabling imaging devices to automatically retrieve patient and appointment data, significantly reducing manual input and potential errors.

Additionally, HL7 (Health Level Seven) inbound scheduling support allows RayCare to receive appointments from external systems such as hospital information systems (HIS), enhancing care coordination and reducing administrative burden. The diagnosis module has been updated with automatic cancer staging aligned with the eighth edition AJCC (American Joint Committee on Cancer) guidelines, supporting more standardized and accurate clinical decision-making. Treatment delivery interoperability has also been expanded, with support for additional platforms and a streamlined user interface for managing beam session workflows. Discover all the new features in RayCare v2025 here. Johan Löf, founder and CEO, RaySearch: "RayCare v2025 reflects our unwavering commitment to advancing integrated, intelligent cancer care.

With every release, we take another step towards a future where oncology teams are empowered by smarter workflows, seamless connectivity, and truly adaptive treatment support." About RaySearch RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.

RaySearch's software has been sold to over 1,100 clinics in 47 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com. Story Continues About RayCare The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today's oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®.

The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future. * Subject to regulatory clearance in some markets. CONTACT: For more information, please contact: Johan Löf, founder and CEO, RaySearch Laboratories AB (publ) Telephone: + 46 (0) 8 510 530 00 [email protected] Learn more about us on: LinkedIn YouTube This information was brought to you by Cision http://news.cision.com https://news.cision.com/raysearch-laboratories/r/raysearch-releases-raycare-v2025,c4170214 The following files are available for download: https://mb.cision.com/Main/1102/4170214/3529182.pdf RaySearch Press Release 27 June 2025 https://news.cision.com/raysearch-laboratories/i/pr-raycare-v2025,c3423202 PR RayCare v2025Cision View original content:https://www.prnewswire.com/news-releases/raysearch-releases-raycare-v2025-302493207.html SOURCE RaySearch Laboratories View Comments

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next